News Focus
News Focus
Replies to #34309 on Biotech Values
icon url

jessellivermore

09/21/06 6:49 PM

#34312 RE: DewDiligence #34309

lol,, you gotta be careful about dem placebos.
icon url

gym gravity

09/22/06 2:03 PM

#34334 RE: DewDiligence #34309

I have to think that DYAX is turning a corner.

It seems they are in the lead now. Also consider they inked a liscencing deal with Serono on Sept 7, which is now a part of Merck. Things seem to be looking better.